SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-019874
Filing Date
2023-02-13
Accepted
2023-02-13 17:15:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm236504d1_sc13g.htm SC 13G 36492
  Complete submission text file 0001104659-23-019874.txt   37731
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93555 | Film No.: 23619933
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA FORT LEE NJ 07024
Business Address
Poradosu Enrique (Filed by) CIK: 0001898147 (see all company filings)

Type: SC 13G